Mounjaro®
Starting from £179.99/mo
Start journey Learn moreDiarrhoea is one of the more common side effects of semaglutide, reported by a meaningful proportion of people during treatment, particularly in the early weeks or after a dose increase. It happens because semaglutide slows the movement of food through your digestive system, and that change takes time for your gut to adjust to. For most people it settles on its own. This page covers why diarrhoea with semaglutide occurs, what typically helps, and the signs that need prompt medical attention. Because semaglutide (sold as Wegovy in the UK for weight management) is a prescription-only medicine, how you manage side effects should always be discussed with your prescribing team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works by activating GLP-1 receptors — the same receptors that tell your brain you're full and slow the rate at which your stomach empties into your small intestine. That slowing effect is central to how the medicine helps with weight loss, but it also means your digestive system is operating differently from what it's used to. For some people, the adjustment tips into loose stools or diarrhoea rather than constipation, which is the other pattern that gets reported.
The NHS medicines page for semaglutide lists diarrhoea among the common side effects, meaning it affects more than one in every hundred users. It tends to cluster around two moments: the first few weeks of starting treatment, and the days following a dose increase. This is the same timing pattern seen across Wegovy's broader side-effect profile. Your gut is not malfunctioning; it's recalibrating.
A quick habit worth building: after each new dose, note roughly how your digestion feels over the first three to five days. A brief mental check (or a note in your phone) can help you tell your prescriber whether symptoms are improving dose by dose or staying static, which informs whether any adjustment is needed.
For the majority of people, diarrhoea caused by semaglutide is self-limiting. The adjustment period after starting or increasing a dose usually spans a few days to around two weeks. If symptoms are uncomfortable but manageable and trending in the right direction, that pattern fits what clinical experience and the prescribing information would predict.
What changes the picture is dose escalation. Each step up the titration ladder can reset the adjustment clock, so someone who had no trouble at a lower dose might experience loose stools again at the next. This is one reason the titration schedule is gradual, it exists partly to give your system time to adapt rather than demanding it cope with a large jump all at once. If you are wondering whether semaglutide can give you diarrhoea and why it happens, there is more detail on the underlying mechanisms worth reading alongside the information on why semaglutide triggers these GI changes.
If diarrhoea persists beyond two weeks on a stable dose, or is severe enough to affect your daily life, that is a signal to contact your prescribing team. It may be that the titration pace needs adjusting, or that something else is contributing. Attributing all GI symptoms automatically to semaglutide without review is a mistake worth avoiding.
There is no single fix, but several things consistently help. Eating smaller meals reduces the workload on a stomach that is already emptying slowly, large portions can accelerate the problem. High-fat and very spicy foods tend to worsen GI side effects across the board, so many people find cutting back during the adjustment period makes a real difference. Fibre intake is worth managing carefully too: some sources help bulk loose stools, while others can worsen urgency.
Hydration is the most underestimated factor. When appetite falls significantly, it is easy to drink less without noticing, and diarrhoea accelerates fluid loss. Plain water, diluted squash or oral rehydration sachets are reasonable options when episodes are frequent. The practical guide to managing diarrhoea on semaglutide on this site covers these steps in more depth, including what not to take without checking with a pharmacist first.
Timing of the injection can also be worth a conversation with your prescriber. Some people find that injecting on a day when they can rest the following day (if their symptoms tend to be worse in the 24 to 48 hours after the pen) makes the adjustment more manageable. That is a personal tweak, not a standard instruction, and your prescribing team should guide it. For related GI symptoms, the advice on managing nausea from semaglutide covers some overlapping strategies.
Most semaglutide-related diarrhoea does not require emergency care. But there are specific situations where it does. Get medical help promptly (call 111 or see a GP urgently) if you experience any of the following: diarrhoea severe enough to prevent you from keeping fluids down, signs of dehydration (dizziness, very dark urine, confusion), or symptoms that show no sign of improving after two weeks on a stable dose.
The situation that warrants calling 999 or going to A&E is severe, persistent abdominal pain, especially pain that spreads to your back, with or without vomiting. In January 2026, the MHRA issued a specific Drug Safety Update for GLP-1 medicines highlighting acute pancreatitis as a known but infrequent serious risk. The symptom pattern described above is the warning signal. Pancreatitis is uncommon, but the combination of persistent severe back-radiating pain and GI upset should not be attributed to ordinary adjustment and left to resolve. The MHRA's Yellow Card scheme allows anyone to report a suspected side effect from a prescription medicine, patients, carers and clinicians alike can submit a report.
For a fuller picture of how diarrhoea specifically fits into Wegovy's side-effect profile, the Wegovy diarrhoea page provides further clinical context. And if you are weighing up treatment options or want to understand what a consultation involves, our clinical team reviews every case individually before any prescription is issued.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.